> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Since Our Last Issue ...
- URL: https://www.fdaweb.com/since-our-last-issue-105/
- Published: 2018-02-04T12:00:00.000Z
- Updated: 2026-09-14T23:19:26.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5140678

**Dextera Surgical** has agreed to sell all assets to **Aesculap**, a **B. Braun** company. The transaction includes the MicroCutter 5/80 Stapler, PAS-Port and C-Port automated anastomosis system cardiac surgery products, and the firm’s technology portfolio. In 12/2017, Dextera filed a voluntary Chapter 11 bankruptcy petition.

**Varian Medical Systems** has acquired privately-held **Mobius Medical Systems**, a provider of radiation oncology quality assurance software. The Mobius QA software is in use at over 1,000 sites worldwide.

**Teva Pharmaceutical Industries** has completed the sale to **CVC Capital Partners** of a portfolio of products within its global women’s health business across contraception, fertility, menopause and osteoporosis for $703 million. The portfolio, which is marketed and sold outside of the U.S., includes Ovaleap, Zoely, Seasonique, Colpotrophine, Actonel and additional products. The business will be known as Theramex.

**Quest Diagnostics** has completed its acquisition of **Mobile Medical Examination Service**, a national provider of home-based health risk assessments and related services. The transaction is intended to strengthen Quest’s mobile provider capabilities and population health management solutions for health plans.